You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 11, 2025

List of Excipients in API clarithromycin


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing clarithromycin

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
Physicians Total Care Inc BIAXIN clarithromycin 54868-3820 CROSCARMELLOSE SODIUM
Physicians Total Care Inc BIAXIN clarithromycin 54868-3820 D&C YELLOW NO. 10
Physicians Total Care Inc BIAXIN clarithromycin 54868-3820 FD&C BLUE NO. 1
Physicians Total Care Inc BIAXIN clarithromycin 54868-3820 HYDROXYPROPYL CELLULOSE
Physicians Total Care Inc BIAXIN clarithromycin 54868-3820 HYPROMELLOSES
Physicians Total Care Inc BIAXIN clarithromycin 54868-3820 MAGNESIUM STEARATE
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Get Started Free

Excipients in ANDA-approved (generic) drugs containing clarithromycin

Company Ingredient NDC Excipient
Lannett Company Inc clarithromycin 0527-1930 GLYCERYL DIBEHENATE
Lannett Company Inc clarithromycin 0527-1930 HYPROMELLOSES
Lannett Company Inc clarithromycin 0527-1930 LACTOSE MONOHYDRATE
Lannett Company Inc clarithromycin 0527-1930 MAGNESIUM STEARATE
Lannett Company Inc clarithromycin 0527-1930 POLYETHYLENE GLYCOL
Lannett Company Inc clarithromycin 0527-1930 TITANIUM DIOXIDE
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Get Started Free

Detailed excipient profiles for clarithromycin

Excipient focus: ALUMINUM OXIDE

Excipient focus: ANHYDROUS CITRIC ACID

Excipient focus: CELLULOSE, MICROCRYSTALLINE

Excipient focus: CITRIC ACID MONOHYDRATE

Excipient focus: COLLOIDAL SILICON DIOXIDE

Excipient focus: CROSCARMELLOSE SODIUM

Excipient focus: D&C YELLOW NO. 10

Excipient focus: D&C YELLOW NO. 10 ALUMINUM LAKE

Excipient focus: ETHYLCELLULOSE

Excipient focus: FD&C BLUE NO. 1

Excipient focus: FD&C YELLOW NO. 6

Excipient focus: FERRIC OXIDE RED

Excipient focus: FERRIC OXIDE YELLOW

Excipient focus: FERROSOFERRIC OXIDE

Excipient focus: GLYCERYL DIBEHENATE

Excipient focus: GLYCERYL MONOSTEARATE

Excipient focus: HYDROXYPROPYL CELLULOSE

Excipient focus: HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED

Excipient focus: HYPROMELLOSE

Excipient focus: HYPROMELLOSE 2208

Excipient focus: HYPROMELLOSE 2910

Excipient focus: HYPROMELLOSES

Excipient focus: LACTOSE MONOHYDRATE

Excipient focus: MAGNESIUM STEARATE

Excipient focus: MALTODEXTRIN

Excipient focus: METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER

Excipient focus: METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER

Excipient focus: POLOXAMER 188

Excipient focus: POLYDEXTROSE

Excipient focus: POLYETHYLENE GLYCOL

Excipient focus: POLYETHYLENE GLYCOL 3000

Excipient focus: POLYETHYLENE GLYCOL 3350

Excipient focus: POLYETHYLENE GLYCOL 400

Excipient focus: POLYETHYLENE GLYCOL 4000

Excipient focus: POLYETHYLENE GLYCOLS

Excipient focus: POLYSORBATE 80

Excipient focus: POLYVINYL ALCOHOL

Excipient focus: POTASSIUM SORBATE

Excipient focus: POVIDONE

Excipient focus: POVIDONE K29/32

Excipient focus: POVIDONE K30

Excipient focus: POVIDONES

Excipient focus: PROPYLENE GLYCOL

Excipient focus: SHELLAC

Excipient focus: SILICON DIOXIDE

Excipient focus: SODIUM PHOSPHATE, MONOBASIC ANHYDROUS

Excipient focus: SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS

Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO

Excipient focus: SODIUM STEARYL FUMARATE

Excipient focus: SORBIC ACID

Excipient focus: SORBITAN MONOOLEATE

Excipient focus: STARCH, CORN

Excipient focus: STEARIC ACID

Excipient focus: SUCROSE

Excipient focus: TALC

Excipient focus: TITANIUM DIOXIDE

Excipient focus: TRIACETIN

Excipient focus: TRIETHYL CITRATE

Excipient focus: VANILLIN

Excipient focus: XANTHAN GUM

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2025 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
 NCE-1 Patent Challenge Dates 2025 - 2026
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links